Pro-inflammatory cytokines: The link between obesity and osteoarthritis

Henderson, 2013, Prevalence, causes, severity, impact, and management of chronic pain in Australian general practice patients, Pain Med. (Malden, Mass.), 14, 1346, 10.1111/pme.12195 Guccione, 1994, The effects of specific medical conditions on the functional limitations of elders in the Framingham Study, Am. J. Public Health, 84, 351, 10.2105/AJPH.84.3.351 Cross, 2014, The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study, Ann. Rheum. Dis., 73, 1323, 10.1136/annrheumdis-2013-204763 Jordan, 2003, EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for International Clinical Studies Including Therapeutic Trials (ESCISIT), Ann. Rheum. Dis., 62, 1145, 10.1136/ard.2003.011742 Triantaphyllidou, 2013, Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet, Osteoarthr. Cartilage, 21, 322, 10.1016/j.joca.2012.11.003 Blagojevic, 2010, Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis, Osteoarthr. Cartilage, 18, 24, 10.1016/j.joca.2009.08.010 Carman, 1994, Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study, Am. J. Epidemiol., 139, 119, 10.1093/oxfordjournals.aje.a116974 Oliveria, 1999, Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee, Epidemiology (Cambridge, Mass.), 10, 161, 10.1097/00001648-199903000-00013 Messier, 2005, Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis, Arthritis Rheum., 52, 2026, 10.1002/art.21139 Hauner, 2005, Secretory factors from human adipose tissue and their functional role, The Proceedings of the Nutrition Society, 64, 163, 10.1079/PNS2005428 Park, 2005, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6, Diabetes Res. Clin. Pract., 69, 29, 10.1016/j.diabres.2004.11.007 Wang, 2011, Effects and relationship of ERK1 and ERK2 in interleukin-1beta-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes, Int. J. Mol. Med., 27, 583 Stannus, 2010, Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults, Osteoarthr. Cartilage, 18, 1441, 10.1016/j.joca.2010.08.016 Urban, 2018, The role of fat and inflammation in the pathogenesis and management of osteoarthritis, Rheumatology (Oxford, England), 57, 10.1093/rheumatology/kex399 Cancello, 2006, Is obesity an inflammatory disease?, Journees annuelles de diabetologie de l’Hotel-Dieu, 115 Wellen, 2005, Inflammation, stress, and diabetes, J. Clin. Invest., 115, 1111, 10.1172/JCI25102 Gnacinska, 2009, Role of adipokines in complications related to obesity: a review, Adv. Med. Sci., 54, 150, 10.2478/v10039-009-0035-2 Miller, 2008, Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intensive weight-loss therapy, J. Am. Geriatr. Soc., 56, 644, 10.1111/j.1532-5415.2007.01636.x Festa, 2001, The relation of body fat mass and distribution to markers of chronic inflammation, Int. J. Obes. Relat. Metab. Disord., 25, 1407, 10.1038/sj.ijo.0801792 Bullo, 2003, Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression, Obes. Res., 11, 525, 10.1038/oby.2003.74 Tilg, 2006, Adipocytokines: mediators linking adipose tissue, inflammation and immunity, nature reviews, Immunology, 6, 772 Huh, 2014, Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity, Mol. Cells, 37, 365, 10.14348/molcells.2014.0074 Frayn, 2003, Integrative physiology of human adipose tissue, Int. J. Obes. Relat. Metab. Disord., 27, 875, 10.1038/sj.ijo.0802326 Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 Dam, 2016, From neutrophils to macrophages: differences in regional adipose tissue depots, Obes. Rev., 17, 1, 10.1111/obr.12335 Mraz, 2014, The role of adipose tissue immune cells in obesity and low-grade inflammation, J. Endocrinol., 222, 10.1530/JOE-14-0283 Vieira-Potter, 2014, Inflammation and macrophage modulation in adipose tissues, Cell. Microbiol., 16, 1484, 10.1111/cmi.12336 Lumeng, 2007, Obesity induces a phenotypic switch in adipose tissue macrophage polarization, J. Clin. Invest., 117, 175, 10.1172/JCI29881 Gordon, 2007, Macrophage heterogeneity and tissue lipids, J. Clin. Invest., 117, 89, 10.1172/JCI30992 Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Invest., 112, 1796, 10.1172/JCI200319246 Francisco, 2018, Adipokines and inflammation: is it a question of weight?, Br. J. Pharmacol., 175, 1569, 10.1111/bph.14181 Winer, 2009, Normalization of obesity-associated insulin resistance through immunotherapy, Nat. Med., 15, 921, 10.1038/nm.2001 Feuerer, 2009, Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters, Nat. Med., 15, 930, 10.1038/nm.2002 Ceddia, 2005, Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis, Int. J. Obes., 29, 1175, 10.1038/sj.ijo.0803025 Nishimura, 2009, CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity, Nat. Med., 15, 914, 10.1038/nm.1964 Winer, 2011, B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies, Nat. Med., 17, 610, 10.1038/nm.2353 Rollins, 1997, Chemokines, Blood, 90, 909, 10.1182/blood.V90.3.909 Boring, 1998, Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis, Nature, 394, 894, 10.1038/29788 Sartipy, 2003, Monocyte chemoattractant protein 1 in obesity and insulin resistance, PNAS, 100, 7265, 10.1073/pnas.1133870100 Shoelson, 2003, Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance, Int. J. Obes. Relat. Metab. Disord., 27, S49, 10.1038/sj.ijo.0802501 Kanda, 2006, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J. Clin. Invest., 116, 1494, 10.1172/JCI26498 Kirk, 2008, Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected], Diabetes, 57, 1254, 10.2337/db07-1061 Cinti, 2005, Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, J. Lipid Res., 46, 2347, 10.1194/jlr.M500294-JLR200 Murano, 2008, Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice, J. Lipid Res., 49, 1562, 10.1194/jlr.M800019-JLR200 Apovian, 2008, Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects, Arterioscler. Thromb. Vasc. Biol., 28, 1654, 10.1161/ATVBAHA.108.170316 Saberi, 2009, Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice, Cell Metab., 10, 419, 10.1016/j.cmet.2009.09.006 Jiao, 2009, Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-jun NH2-terminal kinase pathways, Diabetes, 58, 104, 10.2337/db07-1344 Margetic, 2002, Leptin: a review of its peripheral actions and interactions, Int. J. Obes. Relat. Metab. Disord., 26, 1407, 10.1038/sj.ijo.0802142 Yamamoto, 2005, Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn’s disease, Gut, 54, 789, 10.1136/gut.2004.046516 Qatanani, 2009, Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice, J. Clin. Invest., 119, 531, 10.1172/JCI37273 Wang, 2015, Metabolic triggered inflammation in osteoarthritis, Osteoarthr. Cartilage, 23, 22, 10.1016/j.joca.2014.10.002 Frederich, 1995, Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity, J. Clin. Invest., 96, 1658, 10.1172/JCI118206 MacDougald, 1995, Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes, PNAS, 92, 9034, 10.1073/pnas.92.20.9034 Friedman, 1998, Leptin and the regulation of body weight in mammals, Nature, 395, 763, 10.1038/27376 Fowler-Brown, 2015, The mediating effect of leptin on the relationship between body weight and knee osteoarthritis in older adults, Arthritis Rheumatol. (Hoboken, N.J.), 67, 169, 10.1002/art.38913 Marti, 2001, Obesity and immune function relationships, Obes. Rev., 2, 131, 10.1046/j.1467-789x.2001.00025.x Acedo, 2013, Participation of leptin In the determination of the macrophage phenotype: an additional role In adipocyte and macrophage crosstalk, In vitro cellular & developmental biology, Animal, 49, 473 Koskinen, 2011, Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients, Clin. Exp. Rheumatol., 29, 57 Bao, 2010, Leptin plays a catabolic role on articular cartilage, Mol. Biol. Rep., 37, 3265, 10.1007/s11033-009-9911-x Balsan, 2015, Relationship between adiponectin, obesity and insulin resistance, Revista da Associacao Medica Brasileira, 61, 72, 10.1590/1806-9282.61.01.072 Luo, 2016, Adiponectin: a versatile player of innate immunity, J. Mol. Cell. Biol., 8, 120, 10.1093/jmcb/mjw012 Hao, 2011, Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis, Rheumatol. Int., 31, 1433, 10.1007/s00296-010-1516-0 Kang, 2010, Adiponectin is a potential catabolic mediator in osteoarthritis cartilage, Arthritis Res. Ther., 12, R231, 10.1186/ar3218 Chen, 2006, Evidence for a protective role for adiponectin in osteoarthritis, Biochim. Biophys. Acta, 1762, 711, 10.1016/j.bbadis.2006.06.008 Challa, 2010, Effect of adiponectin on ATDC5 proliferation, differentiation and signaling pathways, Mol. Cell. Endocrinol., 323, 282, 10.1016/j.mce.2010.03.025 Yusuf, 2011, Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis, Ann. Rheum. Dis., 70, 1282, 10.1136/ard.2010.146282 Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627 Akdis, 2011, Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases, J. Allergy Clin. Immunol., 127, 701, 10.1016/j.jaci.2010.11.050 Marks, 2005, Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee, Arthroscopy, 21, 1342, 10.1016/j.arthro.2005.08.034 Garlanda, 2013, The interleukin-1 family: back to the future, Immunity, 39, 1003, 10.1016/j.immuni.2013.11.010 Gabay, 2010, IL-1 pathways in inflammation and human diseases, Nature reviews, Rheumatology, 6, 232 Palomo, 2015, The interleukin (IL)-1 cytokine family--balance between agonists and antagonists in inflammatory diseases, Cytokine, 76, 25, 10.1016/j.cyto.2015.06.017 Luheshi, 1999, Leptin actions on food intake and body temperature are mediated by IL-1, Proceedings of the National Academy of Sciences of the United States of America, 96, 7047, 10.1073/pnas.96.12.7047 Matsuki, 2003, IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions, J. Exp. Med., 198, 877, 10.1084/jem.20030299 Horai, 1998, Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion, J. Exp. Med., 187, 1463, 10.1084/jem.187.9.1463 Jager, 2007, Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression, Endocrinology, 148, 241, 10.1210/en.2006-0692 De Simone, 2015, Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth, Oncogene, 34, 3493, 10.1038/onc.2014.286 Zheng, 2014, TNFalpha promotes Th17 cell differentiation through IL-6 and IL-1beta produced by monocytes in rheumatoid arthritis, J. Immunol. Res., 2014, 385352, 10.1155/2014/385352 Chung, 2009, Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, 30, 576, 10.1016/j.immuni.2009.02.007 Gulen, 2010, The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation, Immunity, 32, 54, 10.1016/j.immuni.2009.12.003 Lee, 2010, Regulating human Th17 cells via differential expression of IL-1 receptor, Blood, 115, 530, 10.1182/blood-2009-08-236521 Guo, 2009, IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells, PNAS, 106, 10.1073/pnas.0906988106 Rider, 2011, IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation, J. Immunol. (Baltimore, Md.: 1950), 187, 4835, 10.4049/jimmunol.1102048 Heraud, 2000, Apoptosis in normal and osteoarthritic human articular cartilage, Ann. Rheum. Dis., 59, 959, 10.1136/ard.59.12.959 L’Hermette, 2006, Articular cartilage, degenerative process, and repair: current progress, Int. J. Sports Med., 27, 738, 10.1055/s-2005-872824 Murphy, 2011, Localizing matrix metalloproteinase activities in the pericellular environment, FEBS J., 278, 2, 10.1111/j.1742-4658.2010.07918.x Malfait, 2002, Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage, J. Biol. Chem., 277, 10.1074/jbc.M200431200 Guo, 2009, Telopeptides of type II collagen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments, Inflammation Res., 58, 161, 10.1007/s00011-009-8090-5 Cortial, 2006, Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in osteoarthritis, Osteoarthr. Cartilage, 14, 631, 10.1016/j.joca.2006.01.008 El Mansouri, 2011, Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes, Arthritis Rheum., 63, 168, 10.1002/art.27762 Gilman, 1988, Interleukin-1 activates phospholipase A2 in human synovial cells, Arthritis Rheum., 31, 126, 10.1002/art.1780310118 Hardy, 2002, Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants, Arthritis Rheum., 46, 1789, 10.1002/art.10356 Blanco, 1995, Chondrocyte apoptosis induced by nitric oxide, Am. J. Pathol., 146, 75 Murrell, 1996, Nitric oxide: an important articular free radical, the journal of bone and joint surgery, Am. Vol., 78, 265 Afonso, 2007, Reactive oxygen species and superoxide dismutases: role in joint diseases, Jt. Bone Spine : revue du rhumatisme, 74, 324, 10.1016/j.jbspin.2007.02.002 Xu, 2014, Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma, Int. J. Biol. Sci., 10, 664, 10.7150/ijbs.8232 Chang, 2001, Mammalian MAP kinase signalling cascades, Nature, 410, 37, 10.1038/35065000 Ahmed, 2005, Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro, J. Nutr., 135, 2096, 10.1093/jn/135.9.2096 Vincenti, 2002, Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors, Arthritis Res., 4, 157, 10.1186/ar401 Kapoor, 2011, Role of proinflammatory cytokines in the pathophysiology of osteoarthritis, nature reviews, Rheumatology, 7, 33 Liacini, 2002, Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes, Matrix Biol., 21, 251, 10.1016/S0945-053X(02)00007-0 Hashimoto, 1997, Fas/Fas ligand expression and induction of apoptosis in chondrocytes, Arthritis Rheum., 40, 1749, 10.1002/art.1780401004 Reichlin, 2000, Blood to brain transfer of leptin in normal and interleukin-1beta-treated male rats, Endocrinology, 141, 1951, 10.1210/endo.141.6.7459 Granowitz, 1997, Transforming growth factor-beta enhances and pro-inflammatory cytokines inhibit ob gene expression in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 240, 382, 10.1006/bbrc.1997.7663 Takahashi, 2008, JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro, American journal of physiology, Endocrinol. Metab., 294, E898 Simons, 2007, Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization, J. Endocrinol., 192, 289, 10.1677/JOE-06-0047 Tracey, 1993, Tumor necrosis factor, other cytokines and disease, Annu. Rev. Cell Biol., 9, 317, 10.1146/annurev.cb.09.110193.001533 Tracey, 1994, Tumor necrosis factor: a pleiotropic cytokine and therapeutic target, Annu. Rev. Med., 45, 491, 10.1146/annurev.med.45.1.491 Clohisy, 2002, Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells, J. Orthopaed. Res., 20, 174, 10.1016/S0736-0266(01)00088-2 Merkel, 1999, Tumor necrosis factor-alpha mediates orthopedic implant osteolysis, Am. J. Pathol., 154, 203, 10.1016/S0002-9440(10)65266-2 Jiranek, 1993, Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization, J. Bone Jt. Surg. Am. Vol., 75, 863, 10.2106/00004623-199306000-00007 Chen, 2005, Ubiquitin signalling in the NF-kappaB pathway, Nat. Cell Biol., 7, 758, 10.1038/ncb0805-758 Hayden, 2004, Signaling to NF-kappaB, Genes Dev., 18, 2195, 10.1101/gad.1228704 Vallabhapurapu, 2009, Regulation and function of NF-kappaB transcription factors in the immune system, Annu. Rev. Immunol., 27, 693, 10.1146/annurev.immunol.021908.132641 Osta, 2014, Classical and paradoxical effects of TNF-alpha on bone homeostasis, Front. Immunol., 5, 48, 10.3389/fimmu.2014.00048 Schulze-Osthoff, 1998, Apoptosis signaling by death receptors, Eur. J. Biochem., 254, 439, 10.1046/j.1432-1327.1998.2540439.x Ramirez Alvarado, 2012, Tumor necrosis factor-alpha, insulin resistance, the lipoprotein metabolism and obesity in humans, Nutricion hospitalaria, 27, 1751 Liang, 2008, Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected wistar rats from diet-induced obesity and insulin resistance, Endocrinology, 149, 2943, 10.1210/en.2007-0978 Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J. Clin. Invest., 95, 2409, 10.1172/JCI117936 Petruschke, 1993, Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells, J. Clin. Endocrinol. Metab., 76, 742 Stephens, 1992, Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis, J. Biol. Chem., 267, 10.1016/S0021-9258(18)42251-X Feingold, 1992, Role of cytokines in inducing hyperlipidemia, Diabetes, 41, 97, 10.2337/diab.41.2.S97 Hube, 1999, The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance?, Hormone Metab. Res. = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 31, 626, 10.1055/s-2007-978810 Suzawa, 2003, Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade, Nat. Cell Biol., 5, 224, 10.1038/ncb942 Wang, 2017, Pro-inflammatory cytokines: New potential therapeutic targets for obesity-related bone disorders, Curr. Drug Targets, 18, 1664, 10.2174/1389450118666170104153512 Algood, 2003, Chemokines and tuberculosis, Cytokine Growth Factor Rev., 14, 467, 10.1016/S1359-6101(03)00054-6 Harris, 2008, Tumor necrosis factor blockers influence macrophage responses to mycobacterium tuberculosis, J. Infect. Dis., 198, 1842, 10.1086/593174 Bekker, 2000, Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent, Infect. Immun., 68, 6954, 10.1128/IAI.68.12.6954-6961.2000 Mootoo, 2009, TNF-alpha in tuberculosis: a cytokine with a split personality, Inflammation Allergy Drug Targets, 8, 53, 10.2174/187152809787582543 Schaible, 2003, Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis, Nat. Med., 9, 1039, 10.1038/nm906 Balcewicz-Sablinska, 1998, Pathogenic mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha, J. Immunol. (Baltimore, Md.: 1950), 161, 2636, 10.4049/jimmunol.161.5.2636 Xue, 2013, Tumor necrosis factor-alpha induces ADAMTS-4 expression in human osteoarthritis chondrocytes, Mol. Med. Rep., 8, 1755, 10.3892/mmr.2013.1729 Goldring, 2004, The role of cytokines in cartilage matrix degeneration in osteoarthritis, Clin. Orthop., 427, S27, 10.1097/01.blo.0000144854.66565.8f Klooster, 2005, Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte, Arthritis Res. Ther., 7, 10.1186/ar1464 Verma, 2011, ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis, J. Cell. Biochem., 112, 3507, 10.1002/jcb.23298 Lefebvre, 1990, Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes, Biochim. Biophys. Acta, 1052, 366, 10.1016/0167-4889(90)90145-4 Murakami, 2000, Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha, J. Biol. Chem., 275, 3687, 10.1074/jbc.275.5.3687 Ye, 2014, c-Jun N-terminal kinase - c-Jun pathway transactivates Bim to promote osteoarthritis, Can. J. Physiol. Pharmacol., 92, 132, 10.1139/cjpp-2013-0228 Lopez-Armada, 2006, Mitochondrial activity is modulated by TNFalpha and IL-1beta in normal human chondrocyte cells, Osteoarthr. Cartilage, 14, 1011, 10.1016/j.joca.2006.03.008 Honorati, 2007, VEGF production by osteoarthritic chondrocytes cultured in micromass and stimulated by IL-17 and TNF-alpha, Connect. Tissue Res., 48, 239, 10.1080/03008200701541767 Guerne, 1990, IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro, J. Immunol. (Baltimore, Md.: 1950), 144, 499, 10.4049/jimmunol.144.2.499 Lotz, 1992, Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes, J. Immunol. (Baltimore, Md.: 1950), 148, 466, 10.4049/jimmunol.148.2.466 Alaaeddine, 2001, Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation, Arthritis Rheum., 44, 1633, 10.1002/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z Martel-Pelletier, 2003, Cyclooxygenase-2 and prostaglandins in articular tissues, Semin. Arthritis Rheum., 33, 155, 10.1016/S0049-0172(03)00134-3 Jones, 2009, Mitogen-activated protein kinase-activated protein kinase 2 (MK2) modulates key biological pathways associated with OA disease pathology, Osteoarthr. Cartilage, 17, 124, 10.1016/j.joca.2008.05.001 Seguin, 2003, TNFalpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1/2 and NF-kappaB signaling pathways, J. Cell. Physiol., 197, 356, 10.1002/jcp.10371 Lu, 2011, Chondroprotective role of sesamol by inhibiting MMPs expression via retaining NF-kappaB signaling in activated SW1353 cells, J. Agric. Food. Chem., 59, 4969, 10.1021/jf1046738 Zhang, 2000, Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release, Mol. Cell. Endocrinol., 159, 79, 10.1016/S0303-7207(99)00194-X Pape, 1988, Effect of tumor necrosis factor on acetyl-coenzyme a carboxylase gene expression and preadipocyte differentiation, Mol. Endocrinol. (Baltimore, Md.), 2, 395, 10.1210/mend-2-5-395 Kirchgessner, 1997, Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes, J. Clin. Invest., 100, 2777, 10.1172/JCI119824 Yamaguchi, 1998, Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro, Biochem. Biophys. Res. Commun., 244, 30, 10.1006/bbrc.1998.8199 Grunfeld, 1996, Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters, J. Clin. Invest., 97, 2152, 10.1172/JCI118653 Sarraf, 1997, Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia, J. Exp. Med., 185, 171, 10.1084/jem.185.1.171 Berkowitz, 1998, Endotoxin-induced alteration in the expression of leptin and beta3-adrenergic receptor in adipose tissue, Am. J. Physiol., 274 Zumbach, 1997, Tumor necrosis factor increases serum leptin levels in humans, J. Clin. Endocrinol. Metab., 82, 4080, 10.1210/jcem.82.12.4408 Ranganathan, 1998, Adipose tissue ob mRNA expression in humans: discordance with plasma leptin and relationship with adipose TNFalpha expression, J. Lipid Res., 39, 724, 10.1016/S0022-2275(20)32561-X Uysal, 1997, Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function, Nature, 389, 610, 10.1038/39335 Kern, 1995, The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase, J. Clin. Invest., 95, 2111, 10.1172/JCI117899 Iwamoto, 2001, The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes, J. Periodontol., 72, 774, 10.1902/jop.2001.72.6.774 Kappes, 2000, Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes, Hormone Metab. Res.= Hormon- und Stoffwechselforschung = Hormones et metabolisme, 32, 548, 10.1055/s-2007-978684 Fasshauer, 2002, Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 290, 1084, 10.1006/bbrc.2001.6307 Kim, 2005, C-jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 327, 460, 10.1016/j.bbrc.2004.12.026 Isa, 2008, 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 373, 429, 10.1016/j.bbrc.2008.06.046 Kamon, 2004, A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance, Biochem. Biophys. Res. Commun., 323, 242, 10.1016/j.bbrc.2004.08.083 Kita, 2005, Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha, Biochem. Biophys. Res. Commun., 331, 484, 10.1016/j.bbrc.2005.03.205 Maeda, 2001, PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein, Diabetes, 50, 2094, 10.2337/diabetes.50.9.2094 Ouchi, 2001, Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, Circulation, 103, 1057, 10.1161/01.CIR.103.8.1057 Scheller, 2011, The pro- and anti-inflammatory properties of the cytokine interleukin-6, Biochim. Biophys. Acta, 1813, 878, 10.1016/j.bbamcr.2011.01.034 Ganeshan, 2012, Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta, J. Immunol., 188, 594, 10.4049/jimmunol.1102389 Naka, 2002, The paradigm of IL-6: from basic science to medicine, Arthritis Res., 4, 10.1186/ar565 Garbers, 2012, Plasticity and cross-talk of interleukin 6-type cytokines, Cytokin Growth Factor Rev., 23, 85, 10.1016/j.cytogfr.2012.04.001 Rose-John, 2015, The soluble interleukin-6 receptor and related proteins, Best practice & research, Clin. Endocrinol. Metab., 29, 787 Mullberg, 1994, The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site, J. Immunol. (Baltimore, Md.: 1950), 152, 4958, 10.4049/jimmunol.152.10.4958 Rose-John, 1994, Soluble receptors for cytokines and growth factors: generation and biological function, Biochem. J., 300, 281, 10.1042/bj3000281 Hibi, 1990, Molecular cloning and expression of an IL-6 signal transducer, gp130, Cell, 63, 1149, 10.1016/0092-8674(90)90411-7 Heinrich, 2003, Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochem. J., 374, 1, 10.1042/bj20030407 Taniguchi, 2014, IL-6 and related cytokines as the critical lynchpins between inflammation and cancer, Semin. Immunol., 26, 54, 10.1016/j.smim.2014.01.001 Wallenius, 2002, Interleukin-6-deficient mice develop mature-onset obesity, Nat. Med., 8, 75, 10.1038/nm0102-75 Peters, 1997, Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice, J. Exp. Med., 185, 755, 10.1084/jem.185.4.755 Baumann, 1996, The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors, Proceedings of the National Academy of Sciences of the United States of America, 93, 8374, 10.1073/pnas.93.16.8374 Cui, 2004, Essential role of STAT3 in body weight and glucose homeostasis, Mol. Cell. Biol., 24, 258, 10.1128/MCB.24.1.258-269.2004 Jansson, 2003, On the site and mechanism of action of the anti-obesity effects of interleukin-6, growth hormone & IGF research : official journal of the growth hormone, Res. Soc. Int. IGF Res. Soc., 13, S28 Wallenius, 2003, The therapeutic potential of interleukin-6 in treating obesity, Expert Opin. Biol. Ther., 3, 1061, 10.1517/14712598.3.7.1061 Katsume, 2002, Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman’s disease like symptoms emerged in IL-6 transgenic mice, Cytokine, 20, 304, 10.1006/cyto.2002.2012 Hashizume, 2010, Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor, Ann. Rheum. Dis., 69, 741, 10.1136/ard.2008.104844 Trujillo, 2004, Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro, J. Clin. Endocrinol. Metab., 89, 5577, 10.1210/jc.2004-0603 Petersen, 2005, Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro, Am. J. Physiology. Endocrinol. Metab., 288, E155, 10.1152/ajpendo.00257.2004 van Hall, 2003, Interleukin-6 stimulates lipolysis and fat oxidation in humans, J. Clin. Endocrinol. Metab., 88, 3005, 10.1210/jc.2002-021687 Mihara, 2012, IL-6/IL-6 receptor system and its role in physiological and pathological conditions, Clin. Sci. (Lond., Engl.: 1979), 122, 143, 10.1042/CS20110340 Kishimoto, 1995, Interleukin-6 family of cytokines and gp130, Blood, 86, 1243, 10.1182/blood.V86.4.1243.bloodjournal8641243 Fonseca, 2009, Interleukin-6 as a key player in systemic inflammation and joint destruction, Autoimmun. Rev., 8, 538, 10.1016/j.autrev.2009.01.012 Korn, 2009, IL-17 and Th17 cells, Annu. Rev. Immunol., 27, 485, 10.1146/annurev.immunol.021908.132710 Stepkowski, 2008, STAT3: an important regulator of multiple cytokine functions, Transplantation, 85, 1372, 10.1097/TP.0b013e3181739d25 Dhodapkar, 2008, Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma, Blood, 112, 2878, 10.1182/blood-2008-03-143222 Liu, 2010, Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease, Nat. Med., 16, 191, 10.1038/nm.2077 Diveu, 2009, IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells, J. Immunol. (Baltimore, Md.: 1950), 182, 5748, 10.4049/jimmunol.0801162 Mathur, 2007, Stat3 and Stat4 direct development of IL-17-secreting Th cells, J. Immunol. (Baltimore, Md.: 1950), 178, 4901, 10.4049/jimmunol.178.8.4901 Camporeale, 2012, IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?, Front. Biosci. (Landmark ed.), 17, 2306, 10.2741/4054 Jego, 2003, Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6, Immunity, 19, 225, 10.1016/S1074-7613(03)00208-5 Neveu, 2009, IL-6 is required for airway mucus production induced by inhaled fungal allergens, J. Immunol. (Baltimore, Md.: 1950), 183, 1732, 10.4049/jimmunol.0802923 de Hooge, 2005, Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging, Osteoarthr. Cartilage, 13, 66, 10.1016/j.joca.2004.09.011 van de Loo, 1997, Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice, Am. J. Pathol., 151, 177 Poree, 2008, Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter, J. Biol. Chem., 283, 4850, 10.1074/jbc.M706387200 Rowan, 2001, Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown, Arthritis Rheum., 44, 1620, 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B Kwan Tat, 2004, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology, Cytokine Growth Factor Rev., 15, 49, 10.1016/j.cytogfr.2003.10.005 Chenoufi, 2001, Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone, J. Cell. Biochem., 81, 666, 10.1002/jcb.1104 Sakao, 2009, Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis, J. Bone Miner. Metab., 27, 412, 10.1007/s00774-009-0058-6 Wang, 2010, Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase a- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation, Am.J. Physiol. Cell Physiol., 298, C1445, 10.1152/ajpcell.00508.2009 Liu, 2006, The role of the interleukin-6/gp130 signaling pathway in bone metabolism, Vitamins Hormones, 74, 341, 10.1016/S0083-6729(06)74014-6 Sopasakis, 2004, High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator, Obes. Res., 12, 454, 10.1038/oby.2004.51 Bruun, 2002, Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro, Mol. Cell. Endocrinol., 190, 91, 10.1016/S0303-7207(02)00007-2 Fasshauer, 2003, Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes, Biochem. Biophys. Res. Commun., 301, 1045, 10.1016/S0006-291X(03)00090-1 Fang, 2018, Funct. Compr. Physiol., 8, 1031, 10.1002/cphy.c170046 Bruun, 2003, Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans, Am. J. Physiol. Endocrinol. Metab., 285, E527, 10.1152/ajpendo.00110.2003 Caron, 1996, Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression, Arthritis Rheum., 39, 1535, 10.1002/art.1780390914 Grunke, 2006, Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade, Ann. Rheum. Dis., 65, 555, 10.1136/ard.2006.053272 Dray, 2007, Arthritis and pain. Future targets to control osteoarthritis pain, Arthritis Res. Ther., 9, 212, 10.1186/ar2178 Strang, 2013, Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis, Atherosclerosis, 229, 174, 10.1016/j.atherosclerosis.2013.04.031 Ericsson, 1991, Influence of age on the metabolism of plasma low density lipoproteins in healthy males, J. Clin. Invest., 87, 591, 10.1172/JCI115034 Antoniou, 2007, Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-alpha therapy in a patient with psoriatic arthritis and psoriasis vulgaris, Br. J. Dermatol., 156, 1090, 10.1111/j.1365-2133.2007.07835.x Lang, 2012, Risk of infections in rheumatoid arthritis patients treated with tocilizumab, Rheumatol. (Oxford, Engl.), 51, 852, 10.1093/rheumatology/ker223